share_log

利德曼(300289.SZ):目前没有直接投资和收购一兮生物的计划

Leadman (300289.SZ): There are currently no plans to directly invest in or acquire Yixi Biotech

Gelonghui Finance ·  May 13 03:12

On May 13, Ge Longhui | Leadman (300289.SZ) said on the investor interactive platform that the company's products in the field of immunotesting mainly include chemiluminescence kits and related diagnostic instruments. The company currently has no plans to directly invest in or acquire Yixi Biotech.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment